Optimizing Antibiotic Prescribing on Discharge to Long-term Care Facilities
优化长期护理机构出院时的抗生素处方
基本信息
- 批准号:9901454
- 负责人:
- 金额:$ 48.09万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-04-01 至 2022-01-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
PROJECT SUMMARY/ABSTRACT
Up to 75% of antibiotic use in long-term care facilities (LTCFs) is inappropriate or unnecessary. In response
and due to increasing evidence of poor outcomes associated with suboptimal antibiotic prescribing in the long-
term care setting, the Centers for Medicare and Medicaid Services (CMS) now require that LTCFs implement
and maintain antimicrobial stewardship programs as a condition for participation. A major challenge to
improving antibiotic utilization in LTCFs is that 40-50% of LTCF antibiotic use is initiated in acute care hospitals
prior to LTCF admission. Furthermore, an estimated 70% of antibiotic prescribing on hospital discharge is
inappropriate and patients prescribed antibiotics on discharge to a LTCF often lack information regarding the
antibiotic indication, duration, and culture results in patients' discharge summaries.
At present, there are no interventions specifically targeting antibiotic prescribing on discharge from acute care
hospitals to LTCFs. Our long-term goal is to improve antibiotic prescribing in LTCFs and associated patient
and resident outcomes. In this application, we will use a mixed methods approach to develop an evidence-
based intervention bundle targeting high-value areas to optimize antibiotic prescribing on discharge from
hospitals to LTCFs. High-value targets for intervention will be prevalent, modifiable, associated with poor
clinical outcomes, and not currently addressed in standard practice. We propose the following specific aims.
Specific Aim 1: Identify high-value targets of interventions to optimize antibiotic prescribing on transition from
hospitals to LTCFs. We will conduct two multi-center retrospective cohort studies: 1) a hospital-focused study
of patients discharged from a network of academic, regional, and community hospitals in Oregon, Washington,
and Wisconsin and 2) a LTCF-focused study of residents admitted from hospitals to 23 LTCFs in Oregon,
California, Nevada, and Wisconsin.
Specific Aim 2: Identify and describe barriers and facilitators of interventions to optimize antibiotic prescribing
on transition from hospitals to LTCFs. We will conduct in-depth qualitative interviews among hospital and LTCF
healthcare providers, nurses, and administrators.
Specific Aim 3: Develop and refine candidate interventions to address high-value targets and gaps identified in
Aims 1 and 2. We will use a collaborative process with key hospital and LTCF stakeholders to refine candidate
interventions and sequentially test acceptability of the intervention bundle.
项目摘要/摘要
在长期护理机构(LTCFs)中,高达75%的抗生素使用是不适当或不必要的。作为回应
由于越来越多的证据表明,从长远来看,与次优抗生素处方相关的不良结果-
在长期护理环境下,医疗保险和医疗补助服务中心(CMS)现在要求LTCFs实施
并将抗菌素管理计划作为参与的条件。面临的一个重大挑战
提高LTCFs的抗生素利用率是40%-50%的LTCFs抗生素使用是在急诊医院开始的
在入院之前。此外,估计70%的出院抗生素处方是
不适当的和患者在出院时给LTCF开抗生素通常缺乏关于
抗生素的适应症、持续时间和培养结果会导致患者的出院总结。
目前,没有专门针对急性护理出院时开抗生素处方的干预措施。
医院到LTCFs。我们的长期目标是改善LTCFs和相关患者的抗生素处方
和居民的结果。在此应用程序中,我们将使用混合方法来开发证据-
针对高价值地区的基础干预捆绑包,优化出院时的抗生素处方
医院到LTCFs。高价值的干预目标将是普遍的、可修改的、与穷人有关的
临床结果,目前没有在标准实践中解决。我们提出了以下具体目标。
具体目标1:确定干预措施的高价值目标,以优化从
医院到LTCFs。我们将进行两项多中心回顾性队列研究:1)以医院为重点的研究
从华盛顿州俄勒冈州的学术、地区和社区医院网络出院的患者,
和威斯康星州,以及2)一项针对俄勒冈州23家LTCFs住院患者的LTCF重点研究,
加利福尼亚州、内华达州和威斯康星州。
具体目标2:确定并描述干预措施的障碍和促进者,以优化抗生素处方
关于从医院到长期合作伙伴关系的过渡。我们将在医院和LTCF之间进行深入的定性访谈
医疗保健提供者、护士和管理员。
具体目标3:制定和完善候选干预措施,以处理#年确定的高价值目标和差距
目标1和目标2。我们将使用与关键医院和LTCF利益相关者的协作流程来完善候选人
并顺序测试干预捆绑包的可接受性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JON P FURUNO其他文献
JON P FURUNO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JON P FURUNO', 18)}}的其他基金
Epidemiology of resistant bacteria in acute-care and long-term care facilities
急症护理和长期护理机构中耐药菌的流行病学
- 批准号:
8113000 - 财政年份:2010
- 资助金额:
$ 48.09万 - 项目类别:
Epidemiology of resistant bacteria in acute-care and long-term care facilities
急症护理和长期护理机构中耐药菌的流行病学
- 批准号:
7911448 - 财政年份:2009
- 资助金额:
$ 48.09万 - 项目类别:
Epidemiology of resistant bacteria in acute-care and long-term care facilities
急症护理和长期护理机构中耐药菌的流行病学
- 批准号:
7758249 - 财政年份:2008
- 资助金额:
$ 48.09万 - 项目类别:
Epidemiology of resistant bacteria in acute-care and long-term care facilities
急症护理和长期护理机构中耐药菌的流行病学
- 批准号:
8011958 - 财政年份:2008
- 资助金额:
$ 48.09万 - 项目类别:
Epidemiology of resistant bacteria in acute-care and long-term care facilities
急症护理和长期护理机构中耐药菌的流行病学
- 批准号:
8412802 - 财政年份:2008
- 资助金额:
$ 48.09万 - 项目类别:
Epidemiology of resistant bacteria in acute-care and long-term care facilities
急症护理和长期护理机构中耐药菌的流行病学
- 批准号:
7470790 - 财政年份:2008
- 资助金额:
$ 48.09万 - 项目类别:
Epidemiology of resistant bacteria in acute-care and long-term care facilities
急症护理和长期护理机构中耐药菌的流行病学
- 批准号:
7569338 - 财政年份:2008
- 资助金额:
$ 48.09万 - 项目类别:
相似国自然基金
水环境中新兴污染物类抗生素效应(Like-Antibiotic Effects,L-AE)作用机制研究
- 批准号:21477024
- 批准年份:2014
- 资助金额:86.0 万元
- 项目类别:面上项目
相似海外基金
New, easy to use, low-cost technologies based on DNA origami biosensing to achieve distributed screening for AMR and improved antibiotic prescribing
基于 DNA 折纸生物传感的易于使用、低成本的新型技术,可实现 AMR 的分布式筛查并改进抗生素处方
- 批准号:
MR/Y034481/1 - 财政年份:2024
- 资助金额:
$ 48.09万 - 项目类别:
Research Grant
Canadian antibiotic prescribing feedback initiative: Building a national framework to combat antimicrobial resistance in primary care (CANBuild-AMR)
加拿大抗生素处方反馈倡议:建立国家框架以应对初级保健中的抗菌药物耐药性 (CANBuild-AMR)
- 批准号:
487020 - 财政年份:2023
- 资助金额:
$ 48.09万 - 项目类别:
Operating Grants
Informatics Approaches to Understand and Reduce Inappropriate Antibiotic Prescribing by Dentists
了解和减少牙医不适当抗生素处方的信息学方法
- 批准号:
10736908 - 财政年份:2023
- 资助金额:
$ 48.09万 - 项目类别:
Antibiotic Prescribing Implementation Laboratory (APrIL)
抗生素处方实施实验室 (APrIL)
- 批准号:
481561 - 财政年份:2023
- 资助金额:
$ 48.09万 - 项目类别:
Operating Grants
Development, Validation and Real-World Application of Comprehensive Metrics to Improve Hospitals' Antibiotic Prescribing
改善医院抗生素处方的综合指标的开发、验证和实际应用
- 批准号:
10636459 - 财政年份:2023
- 资助金额:
$ 48.09万 - 项目类别:
Standardizing Antibiotic Prescribing for Children Hospitalized with Infections using Novel Metrics and Electronic Clinical Decision Support Tools
使用新指标和电子临床决策支持工具标准化住院感染儿童的抗生素处方
- 批准号:
10705784 - 财政年份:2022
- 资助金额:
$ 48.09万 - 项目类别:
Implementing Telemedicine to Improve Appropriate Antibiotic Prescribing for Acute Respiratory Tract Infections
实施远程医疗以改善急性呼吸道感染的适当抗生素处方
- 批准号:
10419727 - 财政年份:2022
- 资助金额:
$ 48.09万 - 项目类别:
Implementing Telemedicine to Improve Appropriate Antibiotic Prescribing for Acute Respiratory Tract Infections
实施远程医疗以改善急性呼吸道感染的适当抗生素处方
- 批准号:
10624848 - 财政年份:2022
- 资助金额:
$ 48.09万 - 项目类别:
Standardizing Antibiotic Prescribing for Children Hospitalized with Infections using Novel Metrics and Electronic Clinical Decision Support Tools
使用新指标和电子临床决策支持工具标准化住院感染儿童的抗生素处方
- 批准号:
10591108 - 财政年份:2022
- 资助金额:
$ 48.09万 - 项目类别:
Active Monitoring" Versus "Wait and See": Tackling Action Bias in Antibiotic Prescribing Through Strategic Decision Framing.
主动监测”与“观望”:通过战略决策框架解决抗生素处方中的行动偏差。
- 批准号:
2738694 - 财政年份:2022
- 资助金额:
$ 48.09万 - 项目类别:
Studentship